Selected topics

Support KEI's work with a donation.



Recent blogs

SCCR 33 More General Statements re the Agenda items

November 14, 2016
General Statements from CEBS, the Africa Group, Group B, China and the E.U.

SCCR 33 Selected General Statement by India for Asia Pacific and Chile for GRULAC

November 14, 2016.
General Statements on the SCCR 33 agenda items

>> INDIA: Thank you, Mr. Chairman. India has the honor to deliver this statement on behalf of the Asia and Pacific group in this 33rd session of the Standing Committee on Copyright and Related Rights. Asia and Pacific Group would like to express its confidence in your experience and your leadership skills. We are confident that your hard work and diligence will yield desired results and help this committee reach a mutual understanding on all outstanding issues.

SCCR 33. November 14, 2016 Agenda and Schedule

Monday November 14, 2016

8 November 2016 - TRIPS Council - India's intervention on the Paragraph 6 Mechanism

On 8 November 2016, India delivered the following statement on Review under Paragraph 8 of the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health.

India’s Interventions at the TRIPS Council meeting (08-09 November 2016)

Agenda Item 7: Review under Paragraph 8 of the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health

SCCR33: Opening statement of the Asia Pacific Group (delivered by India)

Opening Statement by India on behalf of the Asia and the Pacific Group at 33rd Session of the of the Standing Committee on Copyright and Related Rights, delivered by Dr. Sumit Seth (Economic Affairs) on 14 November 2016

Mr. Chair,

India has the honor to deliver the Opening Statement on behalf of the Asia and the Pacific Group in this 33rd Session of the Standing Committee on Copyright and Related Rights.

9 November 2016 - WTO TRIPS Council - EU's intervention on the Report of the UN High-Level Panel on Access to Medicines

On Wednesday, 9 November 2016, the European Union delivered the following statement at the World Trade Organization's (WTO) TRIPS Council's discussions of the United Nations Secretary-General's High Level Panel Report on Access to Medicines.

UNITED NATIONS SECRETARY-GENERAL’S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES

The European Commission takes note of the contribution provided by the Report of the United Nations Secretary-General's High-Level Panel on Access to Medicines.

9 November 2016 - WTO TRIPS Council - EU's intervention on Intellectual Property and Innovation - Regional Innovation Models

Australia, the European Union, Japan, Switzerland, Chinese Taipei and the United States requested the Secretariat of the World Trade Organization (WTO) to place an item on the agenda of the November 2016 TRIPS Council agenda entitled - "Intellectual Property and Innovation: Regional Innovation Models. On 9 November 2016, the European Union delivered the following intervention on regional innovations models. Intellectual Property and Innovation have been on the agenda of the TRIPS Council since 2012.

IP AND INNOVATION: REGIONAL INNOVATION MODELS

9 November 2016 - WTO TRIPS Council - UNCTAD's statement on the Report of the UN High-Level Panel on Access to Medicines

On Wednesday, 9 November 2016, the United Nations Conference on Trade and Development (UNCTAD) delivered the following statement at the World Trade Organization's (WTO) TRIPS Council's discussions of the United Nations Secretary-General's High Level Panel Report on Access to Medicines. UNCTAD informed WTO members that the agency had recently recommended to Secretary-General Ban Ki-moon to consider endorsement of the Report of the High Level Panel.

The Report of the United Nations High Level Panel on Access to Medicine

SCCR 33: Argentina, Colombia and Mexico - Note on the Draft Treaty to Protect Broadcasting Organizations

On 8 November 2016, the World Intellectual Property Organization (WIPO) published a submission by Argentina, Colombia and Mexico entitled, "Note on the Draft Treaty to Protect Broadcasting Organizations" (SCCR/33/5). In their proposal, the proponents (Argentina, Colombia and Mexico) note that negotiations on a WIPO broadcast treaty have gone on for 18 years and 33 sessions of the Standing Committee on Copyright and Related Rights (SCCR).

India Patent Office denies patent for prostate cancer drug sold under brand name Xtandi, generic name enzalutamide

Updated
According to this story, the India Patent Office has denied a patent for the prostate cancer drug sold under the brand name Xtandi (generic name Enzalutamide). Opponents of the patent claimed it was a new form of a known substance, and not eligible in India under Section 3(d) of its patent act.

9 November 2016 - WTO TRIPS Council - India's intervention on the Report of the UN High-Level Panel on Access to Medicines

On Wednesday, 9 November 2016, India delivered the following statement at the World Trade Organization's (WTO) TRIPS Council's discussions of the United Nations Secretary-General's High Level Panel Report on Access to Medicines.

Agenda item 13: the United Nations Secretary-General’s High Level Panel Report on Access to Medicines

Statement by India.

Thank you Chairman.

At the outset, I would like to thank delegations of Brazil, China and South Africa who are also co-sponsors of this agenda item.

9 November 2016 - WTO TRIPS Council - WHO's intervention on the Report of the UN High-Level Panel on Access to Medicines

On Wednesday, 9 November 2016, the World Health Organization (WHO) delivered the following statement at the World Trade Organization's (WTO) TRIPS Council's discussions of the United Nations Secretary-General's High Level Panel Report on Access to Medicines.

COUNCIL FOR TRIPS

8-9 NOVEMBER 2016

WHO STATEMENT

13. THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES

Thank you very much for giving WHO the opportunity to share our feedback on the Report of the High-Level Panel on Access to Medicines.

9 November 2016 - WTO TRIPS Council - Brazil's intervention on the Report of the UN High-Level Panel on Access to Medicines

On 9 November 2016, the World Trade Organization's (WTO) TRIPS Council held discussions on the United Nations Secretary-General’s High-Level Panel Report on Access to Medicines (UN HLP). These timely WTO discussions on the UN HLP germinated from a 27 October 2016 request by Brazil, China, India and South Africa requesting the WTO Secretariat to place a dedicated agenda item for consideration at the 8-9 November 2016 session of the TRIPS Council entitled “the United Nations Secretary-General’s High-Level Panel Report on Access to Medicines.”

Lancet Commission on Essential Medicines Policies publishes 74 page report, endorses delinkage of R&D costs from drug prices

Today The Lancet Commission on Essential Medicines Policies published the 74 page report on "Essential Medicines for Universal Health Coverage." A copy is available here.

The report is rich in data, analysis and recommendations. The report endorses the delinking of R&D costs from drug prices:

Delinking R&D costs from the price of medicines

Some measures that a new President and/or Congress can take to lower drug prices in the near term

KEI and others working in the drug pricing space are frequently asked about measures that a new President or Congress can take to lower drug prices, in the relatively near term. The following is a list of such actions, including some that would require legislation and some that would not.

A comprehensive list of possible actions would be much longer, and this is not such a list. Our list does not include suggestions from several other groups working on drug pricing that deserve consideration, and there is nothing at this point on price spikes.

Syndicate content